2. Academic Validation
  3. MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate through Inhibition of the FAK/PI3K/NFκB Signaling Pathway

MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate through Inhibition of the FAK/PI3K/NFκB Signaling Pathway

  • Cell Mol Gastroenterol Hepatol. 2025 May 29:101548. doi: 10.1016/j.jcmgh.2025.101548.
Linxiang Liu 1,  Bimin Li 1,  Yue Zhang 1,  Yuan Nie 1,  Wang Zhang 2,  Peng Chen 1,  Chenkai Huang 3,  Xuan Zhu 4
Affiliations

Affiliations

  • 1 Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • 2 Department of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • 3 Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Electronic address: hckroy@163.com.
  • 4 Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Electronic address: ndyfy00326@ncu.edu.cn.
PMID: 40449846 DOI: 10.1016/j.jcmgh.2025.101548
Abstract

Background & aims: Liver fibrosis, driven by chronic injury, hinges on hepatic stellate cell (HSC) activation. Microfibrillar-associated protein 4 (MFAP4), an extracellular matrix protein critical for elastic fiber assembly, is up-regulated in hepatic fibrosis, yet its mechanistic role remains unclear.

Methods: Liver fibrosis was induced in wild-type and Mfpa4 knockout mice using CCl4 and TAA, whereas LX-2 cells were activated with transforming growth factor-β1. Bioinformatics analysis, histopathology, double immunofluorescence, flow cytometry, Transwell coculture systems, Western blot, and quantitative polymerase chain reaction were used to identify the primary intrahepatic cell types expressing MFAP4 and assess its effects on HSC activation and Apoptosis.

Results: MFAP4 is up-regulated in cirrhotic livers and is actively expressed in HSC. Single-cell RNA Sequencing analysis and Transwell coculture experiments revealed that the profibrotic effects of MFAP4 were primarily mediated through HSCs rather than hepatocytes. Inhibition of MFAP4 significantly reduces the expression of fibrosis markers in HSC, inhibits their proliferation and migration, whereas overexpression of MFAP4 results in the opposite effect, accompanied by enhanced Apoptosis resistance. In mouse models, global knockout of Mfap4 significantly alleviates CCl4- and TAA-induced liver fibrosis. Mechanistic analysis reveals that MFAP4 binds to Integrin αvβ3 on the HSC membrane, activating the FAK/PI3K/NFκB signaling pathway, which promotes HSC activation and survival, ultimately exacerbating liver fibrosis. Moreover, MFAP4 mediates a self-sustaining feedback loop via Integrin αvβ3, maintaining HSC activation and further promoting fibrosis progression.

Conclusions: MFAP4 governs HSC activation and Apoptosis resistance via Integrin αvβ3-dependent FAK/PI3K/NFκB signaling. Targeting MFAP4 mitigates fibrosis by altering HSC fate.

Keywords

Cell Fate; Hepatic Stellate Cell; Integrin; Liver Fibrosis; MFAP4.

Figures
Products
Inhibitors & Agonists
Other Products